Alabama is known for ranking poorly in terms of chronic illness, which is a major struggle for many residents. The state is now considering SB 252, a bipartisan effort aimed at combatting abuses by pharmacy benefit managers (PBMs) to ensure access to affordable medications. The bill has passed the Senate with no opposition, highlighting the urgent need for PBM reform.
Opposition to SB 252 is based on misinformation, with claims that the bill will increase costs for employers and patients. In reality, the bill does not create new costs but rather regulates existing fees paid to pharmacies for prescription filling. Most PBMs refuse to disclose pricing data, allowing them to manipulate drug prices and steer patients towards higher-priced medications.
SB 252 proposes tying pharmacy reimbursement to Alabama Actual Acquisition Cost, ensuring fair payment for medications. The bill is supported by both Republicans and Democrats in the Senate, showcasing bipartisan commitment to healthcare reform. By passing SB 252, Alabama can lead the way in holding PBMs accountable and prioritizing patient access to affordable medications.
Richard Kirby, Director of Communications for American Pharmacy Cooperative, Inc., emphasizes the importance of transparency, access, and fair payment for pharmacies. The bill is not about politics but about common sense and standing up to corporate interests that prioritize profits over people. It’s time for Alabama to pass SB 252 and make a positive change in the state’s healthcare system.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
